Literature DB >> 11257554

Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation.

J Madill1, C Gutierrez, J Grossman, J Allard, C Chan, M Hutcheon, S H Keshavjee.   

Abstract

BACKGROUND: It is well documented that malnourished and/or obese surgical patients have increased morbidity and mortality post-operatively. Only a few studies investigating the effect of nutritional status on mortality are available pertaining to the transplant population. Since limited data are available on the nutritional status and its effects on mortality in the lung transplant population, we sought to ascertain whether there is an association between mortality and preoperative nutritional status.
METHODS: We examined mortality during the first 3 months after transplantation. Patients were grouped by body mass index (BMI) categories as < 17 kg/m(2), 17 to < 20 kg/m(2), 20 to 25 kg/m(2) (reference group), > 25 to 27 kg/m(2), and > 27 kg/m(2). Additional risk factors retrieved from the pre-transplant records included age, gender, diagnosis, energy requirements, protein requirements, protein and caloric intake, and weight history. Logistic regression for univariate and multivariate analysis for mortality used recipient age, gender, disease category, pre-transplant cytomegalovirus (CMV) serology, transplant type (single or bilateral), and donor age, gender, and CMV serology.
RESULTS: The likelihood estimates or odds ratios (ORs) of the risk of death within 90 days of lung transplantation for the BMI categories compared to the reference group were 3.7 for BMI < 17 kg/m(2) (p = 0.085), 1.6 for BMI < 17 to 20 kg/m(2) (p = 0.455), 3.5 for BMI > 25 to 27 kg/m(2) (p = 0.069), and 5.0 for BMI > 27 kg/m(2) (p = 0.003).
CONCLUSIONS: In patients with a pre-transplant BMI < 17 kg/m(2) or > 25 kg/m(2) the risk of dying within 90 days post-transplant was increased. In patients with a pre-transplant BMI of > 27 kg/m(2) the risk was significantly higher in than the reference group.

Entities:  

Mesh:

Year:  2001        PMID: 11257554     DOI: 10.1016/s1053-2498(00)00315-6

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  24 in total

1.  Severe underweight decreases the survival rate in adult lung transplantation.

Authors:  Teruya Komatsu; Toyofumi F Chen-Yoshikawa; Ayako Oshima; Shin-Ichi Harashima; Akihiro Aoyama; Nobuya Inagaki; Hiroshi Date
Journal:  Surg Today       Date:  2017-03-17       Impact factor: 2.549

Review 2.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

3.  Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Authors:  David J Lederer; Steven M Kawut; Nancy Wickersham; Christopher Winterbottom; Sangeeta Bhorade; Scott M Palmer; James Lee; Joshua M Diamond; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria Crespo; Jonathan B Orens; Joshua R Sonett; Selim M Arcasoy; Lorraine B Ware; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

4.  Physical activity level significantly affects the survival of patients with end-stage lung disease on a waiting list for lung transplantation.

Authors:  Teruya Komatsu; Ayako Oshima; Toyofumi F Chen-Yoshikawa; Shin-Ichi Harashima; Akihiro Aoyama; Nobuya Inagaki; Hiroshi Date
Journal:  Surg Today       Date:  2017-05-24       Impact factor: 2.549

5.  Obesity and underweight are associated with an increased risk of death after lung transplantation.

Authors:  David J Lederer; Jessie S Wilt; Frank D'Ovidio; Matthew D Bacchetta; Lori Shah; Shankari Ravichandran; Jenny Lenoir; Brenda Klein; Joshua R Sonett; Selim M Arcasoy
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

6.  Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.

Authors:  Barbara C S Hamilton; Gabriela R Dincheva; Hanjing Zhuo; Jeffrey A Golden; Marek Brzezinski; Jonathan P Singer; Michael A Matthay; Jasleen Kukreja
Journal:  Clin Transplant       Date:  2018-02-23       Impact factor: 2.863

7.  Improved survival following lung transplantation with long-term use of bilevel positive pressure ventilation in cystic fibrosis.

Authors:  Ori Efrati; Mordechai R Kremer; Asher Barak; Arie Augarten; Nira Reichart; Amir Vardi; Dalit Modan-Moses
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

8.  Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score.

Authors:  Ramiro Fernandez; Niloufar Safaeinili; Chitaru Kurihara; David D Odell; Manu Jain; Malcolm M DeCamp; G R Scott Budinger; Ankit Bharat
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-20       Impact factor: 5.209

9.  Analytic Morphomics Predict Outcomes After Lung Transplantation.

Authors:  Michael J Pienta; Peng Zhang; Brian A Derstine; Binu Enchakalody; William B Weir; Tyler Grenda; Rebecca Goulson; Rishindra M Reddy; Andrew C Chang; Stewart C Wang; Jules Lin
Journal:  Ann Thorac Surg       Date:  2017-12-02       Impact factor: 4.330

10.  Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.

Authors:  Kathleen J Ramos; Siddhartha G Kapnadak; Miranda C Bradford; Ranjani Somayaji; Eric D Morrell; Joseph M Pilewski; Erika D Lease; Michael S Mulligan; Moira L Aitken; Cynthia J Gries; Christopher H Goss
Journal:  Chest       Date:  2020-01-17       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.